Effect of diabetes mellitus on the outcome of patients with resected non-small cell lung carcinoma

Gerontology

Volumn 57, Issue 6, 2011, Pages 497-501

  Bartling, Babett ^a   Simm, Andreas ^a   Sohst, Antonia ^a   Silber, Rolf Edgar ^a   Hofmann, Hans Stefan ^b  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b Hospital Barmherzige Bruder Regensburg   (Germany)

Author keywords

Diabetes mellitus; Lung carcinoma; Nephropathy disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DIABETES MELLITUS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIABETES COMPLICATIONS; DIABETIC NEPHROPATHIES; FEMALE; GERMANY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80255122776     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000323856     Document Type: Article

References (27)

1. Geiger TR, Peeper DS: Metastasis mechanisms. Biochim Biophys Acta 2009; 1796: 293-308.
2. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150. (Pubitemid 46655601)
3. Gesundheitswesen: Gesundheitsberichterstattung des Bundes: Statistisches Jahrbuch 2009. Wiesbaden, Statistisches Bundesamt, 2010, p 27.
4. De Giorgio R, Giovanni B, Cecconi A, Corinaldesi R, Mancini A: Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med 2000; 160: 2217. (Pubitemid 30482731)
5. Stitt AW, Jenkins AJ, Cooper ME: Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 2002; 11: 1205-1223.
6. Nass N, Bartling B, Navarrete Santos A, Scheubel RJ, Borgermann J, Silber RE, Simm A: Advanced glycation end products, diabetes and ageing. Z Gerontol Geriatr 2007; 40: 349-356.
7. Fukami K, Yamagishi S, Ueda S, Okuda S: Role of AGEs in diabetic nephropathy. Curr Pharm Des 2008; 14: 946-952. (Pubitemid 351753281)
8. Henle T, Miyata T: Advanced glycation end products in uremia. Adv Ren Replace Ther 2003; 10: 321-331. (Pubitemid 38036580)
9. Wrobel K, Wrobel K, Garay-Sevilla ME, Nava LE, Malacara JM: Novel analytical approach to monitoring advanced glycosylation end products in human serum with online spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 1997; 43: 1563-1569. (Pubitemid 27396348)
10. Bartling B, Desole M, Rohrbach S, Silber R-E, Simm A: Age-associated changes of extracellular matrix collagen impair lung cancer cell migration. FASEB J 2009; 23: 1510-1520.
11. Satoh H, Ishikawa H, Kurishima K, Ohtsuka M, Sekizawa K: Diabetes is not associated with longer survival in patients with lung cancer. Arch Intern Med 2001; 161: 485. (Pubitemid 32116572)
12. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P: Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103: 792-802. (Pubitemid 36113249)
13. Hanbali A, Al-Khasawneh K, Cole-Johnson C, Divine G, Ali H: Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med 2007; 167: 513. (Pubitemid 46425669)
14. Vasic L: Locally advanced non-small cell lung cancer-pretreatment prognostic factors: disease stage, tumor histopathological characteristics, the patient-related factors. Arch Oncol 2007; 15: 19-23. (Pubitemid 350218857)
15. Win T, Sharples L, Groves AM, Ritchie AJ, Wells FC, Laroche CM: Predicting survival in potentially curable lung cancer patients. Lung 2008; 186: 97-102.
16. Wittekind C, Meyer H-J, Bootz F: TNM Classification of Malignant Tumours. Union Internationale Contre le Cancer, ed 6. Berlin, Springer, 2003.
17. Beasley MB, Brambilla E, Travis WD: The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005; 40: 90-97.
18. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008; 300: 2754-2764.
19. Monami M, Lamanna C, Balzi D, Marchionni N, Mannucci E: Sulphonylureas and cancer: a case-control study. Acta Diabetol 2009; 46: 279-284.
20. Bowker SL, Yasui Y, Veugelers P, Johnson JA: Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia 2010; 53: 1631-1637.
21. Nerlich AG, Hagedorn HG, Boheim M, Schleicher ED: Patients with diabetes-induced microangiopathy show a reduced frequency of carcinomas. In Vivo 1998; 12: 667-670. (Pubitemid 29012001)
22. Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son WJ, de Jong PE, Smit AJ: Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci 2005; 1043: 299-307. (Pubitemid 41123919)
23. Parving HH: Diabetic hypertensive patients. Is this a group in need of particular care and attention? Diabetes Care 1999; 22(suppl 2):B76-B79.
24. Braatvedt GD, Rosie B, Bagg W, Collins J: Current and former smoking increases mortality in patients on peritoneal dialysis. N Z Med J 2006; 119:U1977.
25. Leibson CL, Ransom JE, Olson W, Zimmerman BR, O'Fallon WM, Palumbo PJ: Peripheral arterial disease, diabetes, and mortality. Diabetes Care 2004; 27: 2843-2849. (Pubitemid 39565047)
26. Gold LI: The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 1999; 10: 303-360. (Pubitemid 30058460)
27. Zhu Y, Usui HK, Sharma K: Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin Nephrol 2007; 27: 153-160. (Pubitemid 46553714)